Table 1. Correction p-MEK1/SIRT1 expression and clinic-pathologic parameters of 87 hepatocellular carcinoma patients.
Variable | Total | p-MEK1/SIRT1 (High) | p-MEK1/SIRT1 (Low) | p-value |
---|---|---|---|---|
Age (years) | ||||
≤ 50 | 59 | 30 | 29 | 0.541 |
> 50 | 24 | 14 | 10 | |
Gender | ||||
Female | 15 | 10 | 5 | 0.331 |
Male | 72 | 38 | 34 | |
Tumor stage | ||||
I | 5 | 1 | 4 | < 0.001*** |
II | 39 | 16 | 23 | |
III | 43 | 31 | 12 | |
Tumor size (cm) | ||||
< 5 | 23 | 7 | 16 | 0.012* |
≥ 5 | 59 | 36 | 23 | |
Serum AFP level (ng/ml) | ||||
≤ 20 | 18 | 9 | 9 | 0.721 |
> 20 | 62 | 34 | 28 | |
Tumor recurrence | ||||
− | 45 | 22 | 23 | 0.227 |
+ | 42 | 26 | 16 | |
Necrosis | ||||
+ | 38 | 17 | 21 | 0.395 |
++ | 26 | 19 | 7 | |
+++ | 23 | 12 | 11 | |
Capsular invasion | ||||
− | 27 | 10 | 17 | 0.048* |
+ | 35 | 22 | 13 | |
++ | 25 | 16 | 9 | |
Vascular invasion | ||||
− | 25 | 7 | 18 | < 0.001*** |
+ | 62 | 41 | 21 | |
Interstitial hyperplasia of tumor | ||||
+ | 22 | 13 | 9 | 0.969 |
++ | 36 | 18 | 18 | |
+++ | 29 | 17 | 12 |
Note: (1) *p < 0.05 ***p < 0.001 was considered statistically significant. (2) P-values were calculated with the Person chi-square test. (3) Total number < 87 due to missing data.